Ever/Body Raises $38M In Series B Funding Led By Tiger Global Management
As the cosmetic dermatology industry experiences accelerated growth, the company will use the investment to fuel expansion and double down on its uniquely personalized, tech-driven approach
News provided by
Share this article
NEW YORK, May 25, 2021 /PRNewswire/
Ever/Body, the cosmetic dermatology provider of personalized, tech-enabled services, today announces its raise of $38M in Series B funding, consisting of both venture equity and debt. The round was led by Tiger Global Management, an existing investor in the company. Additional investors include Addition, Fifth Wall, MetaProp, and Gaingels, and existing investors include Declaration Partners, ACME Capital and Redesign Health. The Series B funding brings the company s total capital raised to date to $52M.